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Available online xxxxTelomeres are protective structures present at the ends of linear chromosomes that are important in preventing
genome instability. Telomeres shorten as a result of cellular replication, leading to a permanent cell cycle arrest,
also known as replicative senescence. Senescent cells have been shown to accumulate inmammalian tissue with
age and in a number of age-related diseases, suggesting that they might contribute to the loss of tissue function
observedwith age. In this review, wewill first describe evidence suggesting a key role for senescence in the age-
ing process and elaborate on some of the mechanisms by which telomeres can induce cellular senescence. Fur-
thermore, we will present multiple lines of evidence suggesting that telomeres can act as sensors of both
intrinsic and extrinsic stress as well as recent data indicating that telomere–induced senescence may occur
irrespectively of the length of telomeres.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Cellular senescence was first described by Hayflick andMoorhead as
the progressive and irreversible loss of proliferative potential of human
somatic cells (Hayflick andMoorhead, 1961). This phenomenon is char-
acterized not only by a loss in replicative capacity, but also by a series of
dramatic changes in cellmorphology, gene expression,metabolism, epi-
genetics and others (van Deursen, 2014). It is a stable phenotype, with
senescent cells being able to be kept in culture for several years follow-
ing the initial arrest.. This is an open access article under
s, J.F., Telomeres and Cell SeSo far, the best explanation for replicative senescence is the shorten-
ing of telomeres, regions composed of DNA repeats associatedwith pro-
teins, found at the ends of chromosomes. In the 1990s, it was shown
that telomere regions gradually shorten with cell division and that
this correlates with the induction of cellular senescence (Harley et al.,
1990). Importantly, it was demonstrated that ectopic expression of
the enzyme telomerase, which is capable of elongating telomeres, coun-
teracts telomere shortening driven by cell division and bypasses the se-
nescence arrest (Bodnar et al., 1998). This experiment, demonstrated
that telomere length was the limiting factor in the senescence arrest
and therefore played a causal role in the process.
Since then, great advances have been made in the understanding of
how telomeres are able to signal the senescence arrest. Thesethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lular senescence, driven by telomere dysfunction, has been shown to be
a causal driver of ageing and age-related pathology (van Deursen,
2014).
1.1. Why Is Cellular Senescence Important?
In recent years, important conceptual advances have been made in
terms of our understanding of the role of senescent cells in vivo. It is
now clear, that the impact of senescence in vivo is not restricted to the
loss of proliferative capacity. Apart from the cell-cycle arrest, senescent
cells have been shown to experience dramatic changes in terms of gene
expression, metabolism, epigenome and importantly, have been shown
to have a distinct secretome profile, known as the Senescence-Associat-
ed Secretory Phenotype (SASP) (Coppé et al., 2008), whichmediates the
interactions between senescent and neighboring cells. The SASP in-
cludes pro-inflammatory cytokines as well as growth factors and extra-
cellular matrix degrading proteins and is thought to have evolved as a
way for senescent cells to communicate with the immune system (po-
tentially to facilitate their own clearance), but also as an extracellular
signal to promote the regeneration of tissues through the stimulation
of nearby progenitor cells (van Deursen, 2014). Nonetheless, it has
been shown that a “chronic” SASP is able to induce senescence in adja-
cent young cells, contributing to tissue dysfunction (Acosta et al., 2013)
and paradoxically tumorigenesis (Demaria et al., 2017).
Recent data indicates that senescent cells play a variety of beneficial
roles during processes such as embryonic development, tumor suppres-
sion, wound healing and tissue repair (Krizhanovsky et al., 2008;
Muñoz-Espín et al., 2013; Demaria et al., 2014; Ritschka et al., 2017).
On the other hand, senescent cells have been detected in multiple
age-related diseases and in a variety of different tissues during ageing.
However, only recently, senescent cells have been shown to contribute
causally to the ageing process. Elimination of senescent cells by suicide
gene-mediated ablation of p16Ink4a-expressing senescent cells in INK-
ATTAC mice has resulted in significant improvements in healthspan
and lifespan suggesting that senescent cells are drivers of ageing
(Baker et al., 2011; Baker et al., 2016). This has led the scientific commu-
nity to identify new interventions to target senescence as a therapy
against ageing and age-related diseases (Zhu et al., 2015; Chang et al.,
2016). The positive and negative effects of senescence in different phys-
iological contexts may be a reflection of the ability of the immune sys-
tem to effectively clear senescent cells. It has been speculated that an
“acute” type of senescence plays generally beneficial roles in processes
such as embryonic development and wound-healing, while a “chronic”
type of senescence may contribute to ageing and age-related disease
(van Deursen, 2014). The role of telomeres in the induction of these
two types of senescence is still unclear. However, senescent cells detect-
ed during development, which are present transiently in tissues
(Muñoz-Espín et al., 2013) are not associated with the activation of a
DNA damage response, which suggests that telomeres are unlikely in-
volved in the process.
1.2. What Are Telomeres and How Do They Signal Senescence?
Telomeres are repetitive sequences of DNA (tandem TTAGGG re-
peats), associated with a number of proteins which form a complex
known collectively as the “Shelterin”. It is believed that the “Shelterin”
complex stabilizes a lariat-like structure, named the telomere-loop (or
t-loop for short)with the purpose of shielding the exposed end of linear
chromosomes (de Lange, 2005). Telomeres contain both a C-rich lag-
ging strand and a G-rich leading strand, which contains a 3′ overhang
comprising of single-stranded nucleotide repeats. The overhang is
thought to bind to one of the double-stranded DNA regions and facili-
tate the formation of the t-loop structure (Griffith et al., 1999).
The “Shelterin” complex is composed of six proteins: telomeric re-
peat binding factor 1 (TRF1), telomeric repeat binding factor 2 (TRF2),Please cite this article as: Victorelli, S., Passos, J.F., Telomeres and Cell Se
10.1016/j.ebiom.2017.03.027TRF2 interacting protein (RAP1), TRF1-interacting nuclear factor 2
(TIN2), adrenocortical dysplasia protein homolog (TPP1) and protection
of telomeres 1 (POT1). TRF1 and TRF2 bind to double-stranded
telomeric sequences, whereas POT1 binds to the single-stranded 3′
overhang (Zhong et al., 1992; Bianchi et al., 1997; Bilaud et al., 1997;
Baumann and Cech, 2001).
Why do telomeres shorten? Most somatic cells lack the activity of
the enzyme telomerase and experience, with cell division, a phenome-
non called the “end-replication problem”. This occurs due to the intrin-
sic inability of DNA polymerases to completely replicate the telomere C-
rich lagging-strand. During the process of lagging-strand synthesis, RNA
primers come into play allowing DNA polymerases to initiate DNA rep-
lication. However, upon removal of the last primer at the 3′ end, the
newly synthesized strand will inevitably be a few nucleotides shorter,
resulting in loss of telomere repeats. This phenomenon was first hy-
pothesized independently by Olovnikov and Watson in the early se-
venties (Olovnikov, 1971; Watson, 1972) and confirmed
experimentally in the nineties (Harley et al., 1990).
How do telomeres signal senescence? It has been hypothesized
that with the progressive loss of telomere repeats with cell division
due to the “end-replication problem”, shelterin components may
be displaced from telomere regions and subsequently destabilize
the abovementioned t-loop conformation (Griffith et al., 1999).
This results in the exposure of the telomere end, which becomes rec-
ognized by the DNA repair machinery as a double-strand DNA break.
Evidence supporting this hypothesis originated initially from studies
which demonstrated that deletion of shelterin component TRF2 in
human cells results in the activation and recruitment of proteins in-
volved in the DNA damage response (DDR) such as 53BP1, theMre11
complex and phosphorylated forms of ATM, H2A.X and Rad 17 (Takai
et al., 2003). Similarly, conditional deletion of the 3′ overhang bind-
ing protein Pot1a in mice, results in the activation of a DDR specifi-
cally at telomere regions and induction of senescence (Wu et al.,
2006). Consistent with the idea that progressive telomere shorten-
ing results in the exposure of telomere-ends and subsequent activa-
tion of a DDR, it was shown that replicatively senescent human
fibroblasts accumulate proteins involved in the DDR at telomere re-
gions, including γH2A.X, 53BP1, MDC1 and NBS1 (d'Adda di
Fagagna et al., 2003). In this review, we chose not to embark on a de-
tailed description of the DDR pathways, but will highlight some of
the downstream effector pathways important for senescence induc-
tion. It is well established that a DDR can result in activation of tran-
scription factor p53 which is involved in a variety of processes
including DNA repair, cell-cycle arrest and apoptosis. P53 is a posi-
tive regulator of transcription of p21, a cyclin-dependent kinase in-
hibitor, which is involved in the cell-cycle arrest observed during
senescence both in vitro and in vivo. Consistent with a key role for
p21 in telomere-induced senescence, deletion of p21 improves the
regenerative capacity of intestinal crypts and hematopoietic stem
cells in late-generation telomerase-deficient mice, which contain
critically short telomeres in a variety of tissues and accelerated age-
ing phenotype (Choudhury et al., 2007). Apart from the p53-p21
pathway, p16-Rb is also an important effector pathway of cellular se-
nescence. However, the link between telomere-dysfunction and p16
activation is less understood. For instance, p16 has been shown to be
activated independently from telomere dysfunction in human fibro-
blasts (Herbig et al., 2004). However, a more recent study reported
that deletion of p16 inWrn-deficient mice, which have dysfunctional
telomeres, resulted in increased proliferative capacity of mouse em-
bryonic fibroblasts (Zhang et al., 2012). Furthermore, deletion of
TRF2 was shown to induce p16 activation (Jacobs and de Lange,
2004) However, p16 deficiency in these cells only partially restored
the growth arrest imposed by telomere-dysfunction. Only when
both p16 and p53 were simultaneously inhibited, a complete rescue
in proliferation was observed. This and other studies suggest that
p16 may act as a secondary mechanism (besides the p53-p21nescence - Size Matters Not, EBioMedicine (2017), http://dx.doi.org/
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dysfunction (Beausejour et al., 2003; Jacobs and de Lange, 2004).
There are several lines of evidence to suggest that telomere dysfunc-
tion may play an important role during ageing. Firstly, telomere dys-
function, assessed by the association between DDR proteins and
telomeres, has been shown to increasewith age in vivo in the skin of pri-
mates (Herbig et al., 2006), the liver, gut and lung of mice (Hewitt et al.,
2012; Birch et al., 2015). Secondly, mousemodels where telomere func-
tion has been compromised, suggest a role in the ageing process. Telo-
merase knock-out (mTERC−/−) mice which carry a homozygous
deletion of the RNA component of telomerase (Blasco et al., 1997)
show a generation-dependent telomere shortening, which results in
critically short telomeres and both senescence and apoptosis (Lee et
al., 1998). In these mice, dysfunctional telomeres have been shown to
impact on the function of stem cells, organ regeneration and lifespan
(Wong et al., 2003). Moreover, it has been shown that reintroduction
of telomerase activity in telomerase-deficient mice is able to revert
the premature ageing phenotype observed in tissues such as the spleen,
intestine and testes (Jaskelioff et al., 2011).
2. Stress Accelerates Telomere Shortening
Although cellular replication is amajor contributor to telomere attri-
tion, other factors can affect the rate atwhich telomeres shorten. For ex-
ample, it has been extensively reported that telomere shortening is
accelerated when cells are exposed to mild oxidative stress, leading to
reduced replicative capacity and a phenotype that resembles replicative
senescence (von Zglinicki et al., 1995; von Zglinicki, 2002; Saretzki et al.,
2003). Indeed, reactive oxygen species (ROS) have been implicated as
important players in telomere-dependent senescence, as overexpress-
ing the antioxidant enzyme superoxide dismutase (SOD3) in human fi-
broblasts, or reducing the levels of intracellular peroxide using
antioxidants, are effective in reducing the rate of telomere shortening
and extending replicative lifespan of these cells (von Zglinicki et al.,
2000; Serra et al., 2003). Moreover, studies have demonstrated that
the antioxidant capacity of a cell correlates with its replication potential
and rate of telomere shortening, suggesting a direct relationship be-
tween telomere attrition and the levels of intracellular oxidative stress
(Richter and von Zglinicki, 2007). The role of ROS in telomere dysfunc-
tion has also been extended to in vivo studies, with one study suggesting
that demyelination and axonal damage in multiple sclerosis (MS) pa-
tients are mediated by oxidative stress (Gilgun-Sherki et al., 2004). In-
deed, a more recent report has shown that MS patients have increased
markers of oxidative stress and shorter telomeres when compared to
healthy controls (Guan et al., 2015). Although it is still unclear where
ROS is originated, studies have suggested that mitochondrial-derived
oxidative stress plays an important role in telomere shortening. For ex-
ample, treating fibroblasts with Mito-Q, a mitochondria-targeted anti-
oxidant, significantly reduces the rate of telomere shortening, as well
as being sufficient to extend replicative lifespan under conditions of
hyperoxia (Saretzki et al., 2003). Other studies have demonstrated
that mild mitochondrial uncoupling, which reduces the accumulation
of mitochondrial superoxide, is sufficient to extend the lifespan of
human fibroblasts and decrease the rate of telomere shortening in
these cells, reinforcing the importance of mitochondrial ROS in this pro-
cess (Passos et al., 2007). On the other hand, FCCP treatment, which
causes severe mitochondrial depolarization and thus mitochondrial
dysfunction, increases ROS generation and leads to telomere attrition,
telomere loss and chromosome fusions in mouse embryos (Liu et al.,
2002). Moreover, patients with mitochondrial diseases such as MELAS
and LHON,whodisplay respiratory chain dysfunction, have shorter telo-
meres in white blood cells when compared to healthy subjects, further
supporting a role of mitochondrial dysfunction in telomere shortening
(Oexle and Zwirner, 1997). In addition, many age-related disorders
such as Alzheimer's and cardiovascular disease have been associated
with increased ROS production due to mitochondrial dysfunction (DaiPlease cite this article as: Victorelli, S., Passos, J.F., Telomeres and Cell Se
10.1016/j.ebiom.2017.03.027et al., 2014), as well as with accelerated telomere shortening
(Fyhrquist and Saijonmaa, 2012; Cai et al., 2013).
Telomeres are thought to be favored targets of oxidative attack com-
pared to the rest of the genome due to their high content of guanine
triplets, which are highly susceptible to oxidative modifications
(Oikawa and Kawanishi, 1999). Indeed, single-stranded breaks have
been shown to preferentially accumulate at telomeres in conditions of
mild oxidative stress, and such lesions lead to replication fork stalling,
resulting in incomplete replication of chromosome ends and thus accel-
erated telomere shortening (Petersen et al., 1998; von Zglinicki, 2000).
Additionally, evidence suggests that oxidative damage at telomeres dis-
places shelterin proteins TRF1 and TRF2, whichmight be anothermech-
anismbywhich oxidative stress leads to telomere dysfunction (Opresko
et al., 2005). However, others have recently shown that TRF2 was often
still present at damaged telomeres when cells were exposed to stress,
suggesting that loss of shelterin components is not the sole cause of
telomere dysfunction (Fumagalli et al., 2012). Another feature that
makes telomeres unique is that lesions occurring at these sites are less
efficiently repaired when compared non-telomeric damage (Kruk et
al., 1995). This is mainly due to the presence of shelterin proteins, as
TRF2 and RAP1 have been shown to inhibit NHEJ at telomeres by
preventing the actions of DNA-PK, a double-stranded break repair com-
plex protein, and also by inhibiting ligase-IV-mediated end joining
(Bombarde et al., 2010). In support of this, recruitment of ligase IV as
a response to DNA damage is impaired when double-stranded breaks
(DSBs) are generated adjacent to telomeric repeats in budding yeast
(Fumagalli et al., 2012). In addition, expressing TRF2 adjacent to a DSB
in mammalian cells leads to persistent DNA damage, providing further
evidence to the irreparability of telomeres (Fumagalli et al., 2012). As
well as being involved in senescence induction via telomere dysfunc-
tion, ROS have also been proposed to act as an effector mechanism dur-
ing senescence. We have shown that a DNA damage response can
induce mitochondrial ROS and this is partially dependent on the activa-
tion of p53 and p21 pathways, but also signals from ATM towards
mTORC1 (Passos et al., 2010; Correia-Melo et al., 2016). In accordance
to this, late generation TERC−/− mice, which have dysfunctional telo-
meres, display higher levels of oxidative damage in tissues, which is
ameliorated by deletion of p21 (Passos et al., 2010). Another report
also shows that signaling downstream of short telomeres activates
p53, which binds and represses PGC-1α and PGC-1β promoters leading
to mitochondrial dysfunction (Sahin et al., 2011). It has been suggested
that ROS generated by dysfunctional mitochondria is involved in a feed-
back loop generating further DNA damage such that the DDR is main-
tained, contributing to the stabilization of the senescent phenotype
(Passos et al., 2010; Correia-Melo et al., 2016).
3. Telomere Dysfunction Can Occur Irrespectively of Length
So far, themajority of studies have given evidence to senescence as a
result of telomere shortening. However, several reports now suggest
that telomere dysfunction can also occur in a length-independent man-
ner (Fig. 1). For example, persistent telomeric DDR signaling in response
to genotoxic stress has been shown to occur irrespectively of length in
human fibroblasts in vitro and in mouse neurons in vivo (Fumagalli et
al., 2012). Longer telomeres signaling a DDR have also been implicated
during the ageing process in vivo. Initially, it was believed that murine
cell senescence was mainly mediated by oxidative damage, and oc-
curred independently of telomeres (Parrinello et al., 2003). However,
recent studies suggest otherwise; telomeric DNA damage has been
shown to increase with age in the gut and liver of mice, which occurred
irrespectively of length (Hewitt et al., 2012; Jurk et al., 2014). Length-in-
dependent telomere damage has also been observed in hippocampal
neurons and liver of baboons with age, possibly indicating that this
plays a role in age-related tissue dysfunction by inducing cellular senes-
cence (Fumagalli et al., 2012). Moreover, analysis of individual telo-
meres in small airway epithelial cells in the lung of COPD patients,nescence - Size Matters Not, EBioMedicine (2017), http://dx.doi.org/
Fig. 1. Length-independent telomere damage. Telomere shortening that occurs naturally with each round of cell division ultimately leads to chromosome ends becoming exposed and
activating a DNA damage response, which results in a permanent arrest known as replicative senescence. However, recent evidence suggests that telomeres may serve as highly
sensitive sensors of stress. It is known that mild oxidative stress causes single-stranded breaks to accumulate at telomeres, leading to accelerate shortening and premature cell cycle
arrest. However, it is possible that acute stresses induce telomeric double-stranded breaks which are not efficiently repaired. This results in a persistent DDR signaling, preventing cells
from undergoing further rounds of replication irrespective of their telomere length, a state which can also be called “telomere length-independent senescence”.
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also revealed that damaged telomeres are not significantly shorter than
those not associated with DDR proteins (Birch et al., 2015). This phe-
nomenon also extends to oncogene-induced senescence (OIS), as a
study has demonstrated that dysfunctional telomeres in melanocytic
nevi were not shorter than functional ones (Suram et al., 2012). In
fact, TRF2 was shown to still be present at a fraction of dysfunctional
telomeres, suggesting that shortening and uncapping (i.e. loss of
shelterin proteins) are not the only causes of DDR activation (Suram
et al., 2012). In accordance to this, length-independent telomere dys-
function has also been shown to occur in replicative senescent cells,
where TRF2 and RAP1 were still present in some telomeres positive
for DDR proteins, suggesting that DDR activation at telomeres is not al-
ways a consequence of loss of shelterin components (Kaul et al., 2012).
It has been suggested that DNA damage is more likely to occur at
long telomeres as they represent a more abundant target for lesion for-
mation, possibly explaining the occurrence of length-independent DDR
activation (Fumagalli et al., 2012). Indeed, in a study where telomeres
were elongated in human cancer cells, it was shown that cells with
very long telomeres were more sensitive to ionizing irradiation, sug-
gesting that telomeres above a critical length aremore likely to accumu-
late DSBs (Fairlie and Harrington, 2015). Moreover, a recent Mendelian
randomization study has shown strong associations between long telo-
meres due to germline genetic variation and increased risk for certain
types of cancer (Haycock et al., 2017). However, thus far evidence
does not clearly point out that longer telomeres are preferential targets
of damage over shorter ones. Studies where individual telomere length
was analyzed both inmelanocytic nevi and inmicewere unable to iden-
tify a significant difference in length between damaged and undamaged
telomeres (Hewitt et al., 2012; Suramet al., 2012). One possibility is that
the sensitivity of current techniques available to measure individual
telomere length in tissues is not great enough to detect very short telo-
meres, masking any possible significant differences in length between
dysfunctional and functional telomeres.
Roger Reddel's group have suggested that telomeres may exist in
three different states, providing an explanation to DNA damage signal-
ing at telomeres that still contain shelterin proteins. The first state isPlease cite this article as: Victorelli, S., Passos, J.F., Telomeres and Cell Se
10.1016/j.ebiom.2017.03.027the so-called fully capped or closed state, where telomeric repeats are
sufficiently long such that the T-loop conformation is not compromised,
and shelterin proteins inhibit NHEJ, preventing DDR activation. Howev-
er, if T-loop conformation is lost, telomeres may adopt an intermediate
state, activating a DDRwithout leading to end-to-end fusions due to the
presence of sufficient shelterin proteins. This may occur in a length-de-
pendent and –independentmanner, possibly explaining the presence of
DDR proteins at longer telomeres that still contain components of the
shelterin complex. Lastly, extreme telomere shortening can lead to dis-
ruption of the T-loop, causingDDR activation, a state also known as fully
uncapped. In the latter, telomeric repeats have reached critical lengths
such that there is a loss of shelterin proteins and NHEJ is no longer
inhibited at telomeres, causing end-to-end fusions (Cesare et al.,
2009). Moreover, recent data from our lab and others indicate that a
fourth state may also exist, whereby persistent DDR signaling within
telomeric repeats can occur even in the presence of an undisrupted T-
loop and shelterin components.
A major question which arises from the aforementioned work is if
activation of a DDR within telomere repeats indicates physical DNA
double stranded breaks or is merely changes in chromatin without an
associated lesion. Recently, a newmethodhas been developedwhich al-
lows the accurate detection of physical DNA damage breaks by DNA
damage in situ ligation, followed by proximity ligation assay. Using
thismethod, the authors observed that following acute genotoxic stress,
persistent DNA double stranded breaks occur, in vitro and in vivo, which
co-localise with DDR proteins (Galbiati et al., 2017).
4. Telomere-persistent DNA Damage Is Important For Stabilizing
senescence
Normally, cells can efficiently and rapidly repair DNA damage that
occurs as a result of daily insults; however, studies have shown that
telomeric lesions remain unrepaired for several months both in vitro
and in vivo (Fumagalli et al., 2012; Hewitt et al., 2012). In fact, our
group has demonstrated through live-cell imaging that most of the
long-lived foci co-localized with telomeres in stress-induced senes-
cence (Hewitt et al., 2012). This was also shown to occur in vivo,nescence - Size Matters Not, EBioMedicine (2017), http://dx.doi.org/
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campal neurons of mice even three months after they were exposed
to genotoxic stress (Fumagalli et al., 2012). Research also indicates
that damaged telomeres play a role in oncogene-induced senescence,
preventing human cancer progression. One study showed that persis-
tent telomeric DDR foci occur as a result of oncogene activation in
human cells, as well as replication fork stalling at telomeres and DNA
replication stress (Suram et al., 2012). Accumulation of damage at telo-
meres is also a feature of cancer precursor lesions, such as human
melanocytic nevi, ductal breast hyperplasia, and colonic adenomas, im-
plicating long-lived telomere damage as an important contributor to
tumor-suppressor mechanisms in vivo. It is believed that cells undergo
replication stress as a response to oncogene activation, which causes
telomere shortening and dysfunction in cells that do not express telo-
merase. Ultimately, this induces senescence, and prevents malignant
transformation of somatic cells (Suram et al., 2012). However, recent
studies have demonstrated that telomerase expression in cells arrested
due to OIS is capable of resolving existing telomere damage, and pre-
vents further telomere dysfunction in these cells. Therefore, telomerase
alleviates telomere damage as a result of replication stress in pre-malig-
nant cells, allowing these cells to escape senescence, and contribute to
cancer progression (Meena et al., 2015; Patel et al., 2016).
The irreparability of telomeric DNA damage has been recently chal-
lenged by studies which have provided evidence that DSB repair can
occur at telomeres (Doksani and de Lange, 2016; Mao et al., 2016).
However, repair at telomeres was only observed in proliferating cells,
such as BJ fibroblasts and HeLa cells. Interestingly, HeLa cells, which
are faster dividing cells, display a faster repair kinetics compared to
slower dividing fibroblasts, suggesting that proliferation rate is an im-
portant determinant of telomeric DSB repair (Mao et al., 2016). On the
other hand, when senescence was induced in fibroblasts either by
genotoxic stress or replicative exhaustion, both of which were associat-
edwith increased telomeric DDR signaling, no significant repair at chro-
mosome endswas detected (Maoet al., 2016). By using the CRISPR-Cas9
system to specifically target telomeric repeats, the authors were able to
induce double-stranded breaks specifically at telomeres in 293T cells,
and demonstrated that homologous recombination (HR) plays an im-
portant role in telomere damage repair (Mao et al., 2016). Evidence
for break repair at telomeres has also been provided by de Lange's
group, who expressed an endonuclease coupled to TRF1 (TRF1-FokI)
in order to induce telomeric DSBs in mouse embryonic fibroblasts
(MEFs) (Doksani and de Lange, 2016). Indeed, TRF1-FokI expression
led to increased telomere-associated DNA damage foci and activation
of ATM kinase-dependent signaling in S-phase; however, these breaks
were shown to be efficiently repaired (Doksani and de Lange, 2016).
As well as showing the involvement of homologous recombination in
telomeric DSB processing, it was also proposed that alternative non-ho-
mologous end-joining (alt-NHEJ) plays an important role in repairing
FokI-induced DSBs at telomeres (Doksani and de Lange, 2016). The
aforementioned studies suggest that in dividing cells, particularly in S
phase, telomeric breaks are subjected to repair via HR; however, this
does not occur in senescent cells. It has been suggested that this could
be a consequence of heterochromatin changes that occur during senes-
cence (Narita et al., 2003), making telomeric DNA less accessible for HR
to occur, thus contributing to the persistent DDR signaling observed
(Mao et al., 2016). However, further studies are required to confirm
this hypothesis. In addition, even though itwas reported that generating
telomeric DSBs did not lead to senescence in both cases, it is important
to note that the cells used in these studies are immortalized (Doksani
and de Lange, 2016;Mao et al., 2016). Therefore, it is important to deter-
mine the response of non-immortalized cells to telomere-specific dam-
age as they represent a more physiologically relevant model.
Since persistent telomeric DNA damage is a feature of replicative,
stress- and oncogene-induced senescence, it has been suggested that
unrepaired telomeres provide a source of persistent DDR signaling
which is important to the establishment of senescence (Fumagalli etPlease cite this article as: Victorelli, S., Passos, J.F., Telomeres and Cell Se
10.1016/j.ebiom.2017.03.027al., 2012). However, damage at non-telomeric sites also contributes to
the senescent phenotype. Short-lived, non-telomeric lesions are con-
stantly renewed during replicative and stress-induced senescence. In
fact, these make up about half of the DNA damage foci, and their con-
stant turnover has been suggested to be a result of increased ROS pro-
duction during senescence, as inhibiting ROS generation results in a
rescue of the proliferation arrest in a number of cells (Passos et al.,
2010; Hewitt et al., 2012). Therefore, DNA damage signaling emanating
from both telomeric and non-telomeric regions are important for the
senescent phenotype, although distinguishing the extent of their indi-
vidual contribution to senescence may prove technically challenging.
In summary, substantial evidence is emerging suggesting that telo-
meres do not only act as replicometers, simply determining how
many rounds of division a cell is capable of undergoing. Instead, they
act asmolecular sensors of intrinsic and extrinsic stresses, andmaintain
genomic stability by limiting replication of cells that have accumulated
significant genomic damage.
5. Outstanding Questions
While data strongly suggests that telomere-associated foci, which
can occur irrespectively of telomere length, increase with age and in
several age-related diseases, it remains to be determined whether it is
a better biomarker than telomere length alone particularly in humans.
Further larger studies need to be conducted, however tissue availability
may be a limitation.
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